/
/
/

Shukra Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)80.49
Volume (₹)5.52 L
High (₹)82.36
Upper Circuit95.95
Low (₹)79.64
Lower Circuit63.97
Prev Close79.96
52W High (₹)84.25
Price79.88
52W Low (₹)26.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)3538.41 Cr
Div. Yield (%)0.01
PE Ratio98.16
Debt to Equity0.06
Price to Book15.73
Book Value1.93
EPS (TTM)0.81
Face Value1.00
ROE (%)29.94

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
SHUKRAPHAR-BNSE
LTP
1W Low
1W High
Market cap (₹)
1776-2.25 (-0.13%)
1720.80
1809.65
4,25,150Cr
10036+321 (3.30%)
9866.35
10080.20
2,66,265Cr
4730+94.85 (2.05%)
4555
4730
1,76,301Cr
2306.1-85.9 (-3.59%)
2252.50
2442
1,25,352Cr
1190-54 (-4.34%)
1182.05
1266.15
1,23,591Cr
1372+21.8 (1.61%)
1337.30
1390.70
1,14,351Cr
1400.1+20.1 (1.46%)
1364.75
1400.60
1,12,474Cr
2533.15+44.4 (1.78%)
2457.35
2539
1,02,315Cr
1701.1+23.3 (1.39%)
1656.90
1724.50
97,757Cr
2015+6 (0.30%)
1989.10
2061.55
92,007Cr
79.88+4.93 (6.58%)
74.43
84.25
3,538Cr

Key Highlights of Shukra Pharmaceuticals Ltd Balance Sheet

Shukra Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹43.79Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹43.79Cr, and the reserves and surplus of the company is ₹19.05Cr.

The company has its non-current liabilities with total liabilities of ₹86.77Cr as of 2025-03-31.

The current liabilities are ₹17.28Cr as of 2025-03-31. At the same time, current assets are ₹65.43Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹19.4Cr, provided in the Shukra Pharmaceuticals Ltd financial statements.